Repetitive transcranial magnetic stimulation as an adjunctive treatment for negative symptoms and cognitive impairment in patients with schizophrenia: a randomized, double-blind, sham-controlled trial

References

• Insel TR. Rethinking schizophrenia. Nature. 2010;468(7321):187–193. doi:10.1038/nature0955221068826
   PubMed Web of Science ®Google Scholar
• Fenton WS, McGlashan TH. Antecedents, symptom progression, and long-term outcome of the deficit syndrome in schizophrenia. Am J Psychiatry. 1994;151(3):351–356. doi:10.1176/ajp.151.3.3517906493
   PubMed Web of Science ®Google Scholar
• Milev P, Ho BC, Arndt S, Andreasen NC. Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. Am J Psychiatry. 2005;162(3):495–506. doi:10.1176/appi.ajp.162.3.49515741466
   PubMed Web of Science ®Google Scholar
• Wykes T, Huddy V, Cellard C, Mcgurk SR, Czobor P. A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am J Psychiatry. 2008;164(12):1791–1802.
   Web of Science ®Google Scholar
• Erhart SM, Marder SR, Carpenter WT. Treatment of schizophrenia negative symptoms: future prospects. Schizophr Bull. 2006;32(2):234–237. doi:10.1093/schbul/sbj05516492797
   PubMed Web of Science ®Google Scholar
• Woodward ND, Purdon SE, Meltzer HY, Zald DH. A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. Int J Neuropsychoph. 2005;8(3):457. doi:10.1017/S146114570500516X
   PubMed Web of Science ®Google Scholar
• Keefe RS, Bilder RM, Davis SM, et al. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Arch Gen Psychiatry. 2007;64(6):633–647. doi:10.1001/archpsyc.64.6.63317548746
   PubMed Web of Science ®Google Scholar
• Loo CK, McFarquhar TF, Mitchell PB. A review of the safety of repetitive transcranial magnetic stimulation as a clinical treatment for depression. Int J Neuropsychopharmacol. 2008;11(1):131–147. doi:10.1017/S146114570700771717880752
   PubMed Web of Science ®Google Scholar
• Strafella AP, Paus T, Barrett J, Dagher A. Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. J Neurosci. 2001;21(15):RC157. doi:10.1523/JNEUROSCI.21-15-j0003.200111459878
   PubMed Web of Science ®Google Scholar
• Eisenegger C, Treyer V, Fehr E, Knoch D. Time-course of “off-line” prefrontal rTMS effects–a PET study. NeuroImage. 2008;42(1):379–384. doi:10.1016/j.neuroimage.2008.04.17218511301
   PubMed Web of Science ®Google Scholar
• Pell GS, Roth Y, Zangen A. Modulation of cortical excitability induced by repetitive transcranial magnetic stimulation: influence of timing and geometrical parameters and underlying mechanisms. Prog Neurobiol. 2011;93(1):59–98. doi:10.1016/j.pneurobio.2010.10.00321056619
   PubMed Web of Science ®Google Scholar
• Hill K, Mann L, Laws KR, Stephenson CM, Nimmo-Smith I, McKenna PJ. Hypofrontality in schizophrenia: a meta-analysis of functional imaging studies. Acta Psychiatr Scand. 2004;110(4):243–256. doi:10.1111/j.1600-0447.2004.00376.x15352925
   PubMed Web of Science ®Google Scholar
• Remington G, Agid O, Foussias G. Schizophrenia as a disorder of too little dopamine: implications for symptoms and treatment. Expert Rev Neurother. 2011;11(4):589–607. doi:10.1586/ern.10.19121469931
   PubMed Web of Science ®Google Scholar
• Cho SS, Strafella AP. rTMS of the left dorsolateral prefrontal cortex modulates dopamine release in the ipsilateral anterior cingulate cortex and orbitofrontal cortex. PLoS One. 2009;4(8):e6725. doi:10.1371/journal.pone.000672519696930
   PubMed Web of Science ®Google Scholar
• Freitas C, Fregni F, Pascual-Leone A. Meta-analysis of the effects of repetitive transcranial magnetic stimulation (rTMS) on negative and positive symptoms in schizophrenia. Schizophr Res. 2009;108(1–3):11–24. doi:10.1016/j.schres.2008.11.02719138833
   PubMed Web of Science ®Google Scholar
• Dlabac-de Lange JJ, Knegtering R, Aleman A. Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: review and meta-analysis. J Clin Psychiatry. 2010;71(4):411–418. doi:10.4088/JCP.08r04808yel20361909
   PubMed Web of Science ®Google Scholar
• Shi C, Yu X, Cheung EF, Shum DH, Chan RC. Revisiting the therapeutic effect of rTMS on negative symptoms in schizophrenia: a meta-analysis. Psychiatry Res. 2014;215(3):505–513. doi:10.1016/j.psychres.2013.12.01924411074
   PubMed Web of Science ®Google Scholar
• Barr MS, Farzan F, Rusjan PM, Chen R, Fitzgerald PB, Daskalakis ZJ. Potentiation of gamma oscillatory activity through repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex. Neuropsychopharmacol. 2009;34(11):2359–2367. doi:10.1038/npp.2009.79
   PubMed Web of Science ®Google Scholar
• Barr MS, Farzan F, Rajji TK, et al. Can repetitive magnetic stimulation improve cognition in schizophrenia? Pilot data from a randomized controlled trial. Biol Psychiatry. 2013;73(6):510–517. doi:10.1016/j.biopsych.2012.08.02023039931
   PubMed Web of Science ®Google Scholar
• Hasan A, Guse B, Cordes J, et al. Cognitive effects of high-frequency rTMS in schizophrenia patients with predominant negative symptoms: results from a multicenter randomized sham-controlled trial. Schizophr Bull. 2016;42(3):608–618. doi:10.1093/schbul/sbv14226433217
   PubMed Web of Science ®Google Scholar
• Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261–276.3616518
   PubMed Web of Science ®Google Scholar
• Andreasen NC. Negative symptoms in schizophrenia. Definition and reliability. Arch Gen Psychiatry. 1982;39(7):784–788.7165477
   PubMed Web of Science ®Google Scholar
• Guy W. Early Clinical Drug Evaluation (ECDEU) Assessment Manual. Rockville: National Institute Mental Health; 1976.
   Google Scholar
• Shi C, Kang L, Yao S, et al. The MATRICS Consensus Cognitive Battery (MCCB): Co-norming and standardization in China. Schizophr Res. 2015;169(1–3):109. doi:10.1016/j.schres.2015.09.00326441005
   PubMed Web of Science ®Google Scholar
• Daskalakis ZJ, Möller B, Christensen BK, Fitzgerald PB, Gunraj C, Chen R. The effects of repetitive transcranial magnetic stimulation on cortical inhibition in healthy human subjects. Exp Brain Res. 2006;174(3):403–412. doi:10.1007/s00221-006-0472-016683138
   PubMed Web of Science ®Google Scholar
• Homan RW, Herman J, Purdy P. Cerebral location of international 10–20 system electrode placement. Electroencephalogr Clin Neurophysiol. 1987;66(4):376–382.2435517
   PubMedGoogle Scholar
• Herwig U, Padberg F, Unger J, Spitzer M, Schonfeldt-Lecuona C. Transcranial magnetic stimulation in therapy studies: examination of the reliability of “standard” coil positioning by neuronavigation. Biol Psychiatry. 2001;50(1):58–61.11457424
   PubMed Web of Science ®Google Scholar
• Herwig U, Satrapi P, Schönfeldtlecuona C. Using the international 10–20 EEG system for positioning of transcranial magnetic stimulation. Brain Topogr. 2003;16(2):95–99.14977202
   PubMed Web of Science ®Google Scholar
• Wassermann EM. Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5–7, 1996. Electroencephalogr Clin Neurophysiol. 1998;108(1):1–16.9474057
   PubMedGoogle Scholar
• Bilek E, Schafer A, Ochs E, et al. Application of high-frequency repetitive transcranial magnetic stimulation to the DLPFC alters human prefrontal-hippocampal functional interaction. J Neurosci. 2013;33(16):7050–7056. doi:10.1523/JNEUROSCI.3081-12.201323595762
   PubMed Web of Science ®Google Scholar
• Prikryl R, Kasparek T, Skotakova S, Ustohal L, Kucerova H, Ceskova E. Treatment of negative symptoms of schizophrenia using repetitive transcranial magnetic stimulation in a double-blind, randomized controlled study. Schizophr Res. 2007;95(1–3):151–157. doi:10.1016/j.schres.2007.06.01917689931
   PubMed Web of Science ®Google Scholar
• Prikryl R, Ustohal L, Prikrylova Kucerova H, et al. A detailed analysis of the effect of repetitive transcranial magnetic stimulation on negative symptoms of schizophrenia: a double-blind trial. Schizophr Res. 2013;149(1–3):167–173. doi:10.1016/j.schres.2013.06.01523810122
   PubMed Web of Science ®Google Scholar
• Quan WX, Zhu XL, Qiao H, et al. The effects of high-frequency repetitive transcranial magnetic stimulation (rTMS) on negative symptoms of schizophrenia and the follow-up study. Neurosci Lett. 2015;584:197–201. doi:10.1016/j.neulet.2014.10.02925449864
   PubMed Web of Science ®Google Scholar
• Zhao S, Kong J, Li S, Tong Z, Yang C, Zhong H. Randomized controlled trial of four protocols of repetitive transcranial magnetic stimulation for treating the negative symptoms of schizophrenia. Shanghai Arch Psychiatry. 2014;26(1):15–21. doi:10.3969/j.issn.1002-0829.2014.01.00325114477
   PubMedGoogle Scholar
• Cohen E, Bernardo M, Masana J, et al. Repetitive transcranial magnetic stimulation in the treatment of chronic negative schizophrenia: a pilot study. J Neurol Neurosurg Psychiatry. 1999;67(1):129–130.10454880
   PubMed Web of Science ®Google Scholar
• Novak T, Horacek J, Mohr P, et al. The double-blind sham-controlled study of high-frequency rTMS (20Hz) for negative symptoms in schizophrenia: negative results. Neuroendocrinol Lett. 2006;27(1–2):209–213.16648775
   PubMed Web of Science ®Google Scholar
• Barr MS, Farzan F, Tran LC, Fitzgerald PB, Daskalakis ZJ. A randomized controlled trial of sequentially bilateral prefrontal cortex repetitive transcranial magnetic stimulation in the treatment of negative symptoms in schizophrenia. Brain Stimul. 2012;5(3):337–346. doi:10.1016/j.brs.2011.06.00321782542
   PubMed Web of Science ®Google Scholar
• Umbricht DS, Wirshing WC, Wirshing DA, et al. Clinical predictors of response to clozapine treatment in ambulatory patients with schizophrenia. J Clin Psychiatry. 2002;63(5):420–424.12019667
   PubMed Web of Science ®Google Scholar
• Mogg A, Purvis R, Eranti S, et al. Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: a randomized controlled pilot study. Schizophr Res. 2007;93(1–3):221–228. doi:10.1016/j.schres.2007.03.01617478080
   PubMed Web of Science ®Google Scholar
• Uhlhaas PJ, Wolf S. Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci. 2010;11(2):100–113. doi:10.1038/nrn277420087360
   PubMed Web of Science ®Google Scholar
• Barr MS, Farzan F, Arenovich T, Chen R, Fitzgerald PB, Daskalakis ZJ. The effect of repetitive transcranial magnetic stimulation on gamma oscillatory activity in schizophrenia. PLoS One. 2011;6(7):e22627. doi:10.1371/journal.pone.002262721818354
   PubMed Web of Science ®Google Scholar
• Schneider AL, Schneider TL, Stark H. Repetitive transcranial magnetic stimulation (rTMS) as an augmentation treatment for the negative symptoms of schizophrenia: a 4-week randomized placebo controlled study. Brain Stimul. 2008;1(2):106–111. doi:10.1016/j.brs.2008.01.00120633377
   PubMed Web of Science ®Google Scholar
• Desamericq G, Schurhoff F, Meary A, et al. Long-term neurocognitive effects of antipsychotics in schizophrenia: a network meta-analysis. Eur J Clin Pharmacol. 2014;70(2):127–134. doi:10.1007/s00228-013-1600-y24145817
   PubMed Web of Science ®Google Scholar
• Nuechterlein KH, Green MF, Kern RS, et al. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am J Psychiatry. 2008;165(2):203–213. doi:10.1176/appi.ajp.2007.0701004218172019
   PubMed Web of Science ®Google Scholar
• Wobrock T, Guse B, Cordes J, et al. Left prefrontal high-frequency repetitive transcranial magnetic stimulation for the treatment of schizophrenia with predominant negative symptoms: a sham-controlled, randomized multicenter trial. Biol Psychiatry. 2015;77(11):979–988. doi:10.1016/j.biopsych.2014.10.00925582269
   PubMed Web of Science ®Google Scholar